FDA Adverse Event Injury Summary report: N

TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 793393 · Received December 8, 2006

Report

Report Number
6000093-2006-02551
Event Type
Injury
Date Received
December 8, 2006
Date of Event
September 10, 2006
Report Date
November 10, 2006
Manufacturer
BOSTON SCIENTIFIC CORP.
Product Code
NIQ
PMA / PMN Number
p030025
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

H6; THE DELIVERY DEVICE WAS DISPOSED AND THE STENT REMAINED IN THE PT. THE MFG RECORDS FOR TOP ASSEMBLY BATCH 8132603 HAVE BEEN REVIEWED AND NO ISSUES OR DISCREPANCIES WERE FOUND. THIS RECORDS REVIEW CONFIRMS THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY, AND PERFORMANCE SPECS. THE CAUSE OF THE DIFFICULTIES STATED IN THE COMPLAINT COULD NOT BE DETERMINED.

Description of Event or Problem · 1

CLINICAL TRIAL. IT WAS REPORTED THAT POST INDEX PROCEDURE, THE PT EXPERIENCED CHEST PAIN. THE INDEX PROCEDURE TREATED A BIFURCATED LESION CONSISTING OF THE LEFT MAIN, PROXIMAL LAD AND CIRCUMFLEX ARTERIES. THE PHYSICIAN DIRECT STENTED THE LESION WITH A 5.0X32MM TAXUS EXPRESS2 STENT, USING THE T-STENTING TECHNIQUE. POST DILATATION STENOSIS IS LESS THAN OR EQUAL TO 30%. THE PT RECEIVED BIVALIRUDIN DURING THE PROCEDURE. THE PT WAS DISCHARGED 1 DAY LATER ON ASPIRIN AND PLAVIX. ON DAY 130, THE PT EXPERIENCED CHEST PAIN. THE PT WAS TAKEN FOR AN ANGIOGRAM, BUT NO OTHER INTERVENTION WAS PERFORMED. AT THAT TIME, THE PT WAS SCHEDULED FOR A PERCUTANEOUS CORONARY INTERVENTION AT ANOTHER HOSP.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM NIQ STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC CORP. 5.0X32MM 8132603

Patients

Seq Age Sex Outcome Treatment
1 64 YR Hospitalization| L| R